Panagene Inc (046210) - Net Assets

Latest as of September 2025: ₩77.27 Billion KRW ≈ $52.36 Million USD

Based on the latest financial reports, Panagene Inc (046210) has net assets worth ₩77.27 Billion KRW (≈ $52.36 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩101.91 Billion ≈ $69.07 Million USD) and total liabilities (₩24.65 Billion ≈ $16.70 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of Panagene Inc to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩77.27 Billion
% of Total Assets	75.81%
Annual Growth Rate	9.35%
5-Year Change	203.32%
10-Year Change	753.8%
Growth Volatility	50.5

Panagene Inc - Net Assets Trend (2005–2024)

This chart illustrates how Panagene Inc's net assets have evolved over time, based on quarterly financial data. Also explore Panagene Inc balance sheet assets for the complete picture of this company's asset base.

Annual Net Assets for Panagene Inc (2005–2024)

The table below shows the annual net assets of Panagene Inc from 2005 to 2024. For live valuation and market cap data, see Panagene Inc (046210) market capitalisation.

Year	Net Assets	Change
2024-12-31	₩76.04 Billion ≈ $51.53 Million	+19.62%
2023-12-31	₩63.57 Billion ≈ $43.08 Million	+100.61%
2022-12-31	₩31.69 Billion ≈ $21.48 Million	+6.18%
2021-12-31	₩29.84 Billion ≈ $20.22 Million	+19.04%
2020-12-31	₩25.07 Billion ≈ $16.99 Million	+24.08%
2019-12-31	₩20.20 Billion ≈ $13.69 Million	+23.93%
2018-12-31	₩16.30 Billion ≈ $11.05 Million	-17.82%
2017-12-31	₩19.84 Billion ≈ $13.44 Million	-5.97%
2016-12-31	₩21.10 Billion ≈ $14.30 Million	+136.88%
2015-12-31	₩8.91 Billion ≈ $6.04 Million	-0.19%
2012-12-31	₩8.92 Billion ≈ $6.05 Million	-44.01%
2011-12-31	₩15.94 Billion ≈ $10.80 Million	-4.36%
2010-12-31	₩16.66 Billion ≈ $11.29 Million	-7.03%
2009-12-31	₩17.92 Billion ≈ $12.15 Million	-30.75%
2008-12-31	₩25.88 Billion ≈ $17.54 Million	-24.18%
2007-12-31	₩34.14 Billion ≈ $23.14 Million	+10.35%
2006-12-31	₩30.94 Billion ≈ $20.97 Million	+122.13%
2005-12-31	₩13.93 Billion ≈ $9.44 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Panagene Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 6103827490000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	₩21.25 Billion	27.95%
Other Components	₩115.83 Billion	152.32%
Total Equity	₩76.04 Billion	100.00%

Panagene Inc Competitors by Market Cap

The table below lists competitors of Panagene Inc ranked by their market capitalization.

Company	Market Cap
2S Metal Public Company Limited BK:2S	$46.29 Million
Davolink Inc. KQ:340360	$46.29 Million
Yuasa Battery (Thailand) Public Company Limited BK:YUASA	$46.29 Million
Sequana Medical NV BR:SEQUA	$46.31 Million
Shalimar Paints Limited NSE:SHALPAINTS	$46.28 Million
Tirathai Public Company Limited BK:TRT	$46.27 Million
Duksung KO:004830	$46.27 Million
XChange TEC.INC NASDAQ:XHG	$46.26 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Panagene Inc's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 63,572,923,440 to 76,043,116,760, a change of 12,470,193,320 (19.6%).
Net loss of 1,943,932,240 reduced equity.
Share repurchases of 38,390,000 reduced equity.
New share issuances of 38,390,000 increased equity.
Other factors increased equity by 14,414,125,560.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	₩-1.94 Billion	-2.56%
Share Repurchases	₩38.39 Million	-0.05%
Share Issuances	₩38.39 Million	+0.05%
Other Changes	₩14.41 Billion	+18.96%
Total Change	₩-	19.62%

Book Value vs Market Value Analysis

This analysis compares Panagene Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.19x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 2.99x to 1.19x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩710.77	₩2125.00	x
2017-12-31	₩621.08	₩2125.00	x
2018-12-31	₩508.94	₩2125.00	x
2019-12-31	₩628.71	₩2125.00	x
2020-12-31	₩780.11	₩2125.00	x
2021-12-31	₩928.65	₩2125.00	x
2022-12-31	₩986.08	₩2125.00	x
2023-12-31	₩1550.39	₩2125.00	x
2024-12-31	₩1788.94	₩2125.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Panagene Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -2.56%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -14.73%
• Asset Turnover: 0.12x
• Equity Multiplier: 1.44x
Recent ROE (-2.56%) is above the historical average (-15.48%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2009	-74.89%	-41.50%	0.98x	1.84x	₩-15.22 Billion
2010	-24.25%	-11.87%	0.89x	2.30x	₩-5.71 Billion
2011	-9.99%	-3.84%	0.98x	2.66x	₩-3.19 Billion
2012	-83.36%	-25.97%	1.12x	2.86x	₩-8.33 Billion
2015	-7.07%	-10.64%	0.23x	2.88x	₩-1.52 Billion
2016	-7.38%	-22.38%	0.21x	1.57x	₩-3.67 Billion
2017	-35.08%	-94.11%	0.27x	1.41x	₩-8.94 Billion
2018	-25.26%	-53.46%	0.32x	1.48x	₩-5.75 Billion
2019	17.35%	44.09%	0.36x	1.08x	₩1.48 Billion
2020	19.61%	30.22%	0.60x	1.09x	₩2.41 Billion
2021	16.64%	31.84%	0.49x	1.07x	₩1.98 Billion
2022	7.07%	15.81%	0.41x	1.09x	₩-928.43 Million
2023	-7.57%	-39.30%	0.13x	1.43x	₩-11.17 Billion
2024	-2.56%	-14.73%	0.12x	1.44x	₩-9.55 Billion

Industry Comparison

This section compares Panagene Inc's net assets metrics with peer companies in the Biotechnology & Medical Research industry.

Industry Context

Industry: Biotechnology & Medical Research
Average net assets among peers: $99,003,341,317
Average return on equity (ROE) among peers: -7.92%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Panagene Inc (046210)	₩77.27 Billion	-74.89%	0.32x	$46.28 Million
Macrogen Inc (038290)	$60.05 Billion	10.75%	0.46x	$110.15 Million
Cell Biotech Co. Ltd (049960)	$99.98 Billion	3.19%	0.05x	$83.71 Million
Bioneer Corporation (064550)	$234.88 Billion	-4.51%	0.34x	$157.84 Million
MEDIPOST Co. Ltd (078160)	$146.48 Billion	1.90%	0.25x	$290.79 Million
Biotoxtech Co. Ltd (086040)	$24.54 Billion	4.26%	0.96x	$32.80 Million
Peptron Inc (087010)	$28.09 Billion	-63.08%	1.17x	$2.71 Billion

About Panagene Inc

KQ:046210 Korea Biotechnology & Medical Research

Market Cap

$46.28 Million

₩68.29 Billion KRW

Market Cap Rank

#22171 Global

#1484 in Korea

Share Price

₩2125.00

Change (1 day)

+0.47%

52-Week Range

₩1547.00 - ₩2650.00

All Time High

₩12000.00